Fellows and early career physicians are invited to CVI's pre-conference Fellows Bootcamp on 7/17 in Denver, CO. It's complimentary with your CVI registration. More info: cvinnovations.org/2024/04/07/fel…
#cme #cardiology #fellows hip #fellows

First two Evolut FX+ TAVR in Minnesota by Allina Health MHI Valve team. Commissural alignment and large windows for easy coronary reaccess. True game changer! More to come at #CVI2024 .
Paul vinayak bapat Marcus R. Burns João Cavalcante Nadira Hamid Mario Goessl Jai Parekh

We're excited to make our #EuroPCR debut next week! Dr. Paul Sorajja (Paul) will be presenting pre-clinical results with the Adona technology during Innovator's Day.

“We cannot take this anymore”
Radiation and orthopedic hazards in #IC by SCAI_Prez
Hospitals have a moral obligation to provide radiation protection tool for their most valuable assets-the physicians
@SCAI #SCAI2024 #Cardiotwitter

Last week we Endeavor Health performed 1st commercial TV #TEER w/in 400 mi of Chicago using #Triclip Abbott Cardiovascular. Along w #triluminate PI Paul among very 1st in US. Looking forward to offering this and more transcatheter rx for our valve pts John P Erwin III MD MBA FACC

Very privileged to perform the first commercial Tricuspid Clip procedure in Houston TX yesterday with our team including Nadeen N. Faza, M.D. Stephen Little, MD Joe Aoun Houston Methodist Abbott Cardiovascular Cary Darling. Very exciting new technology that was FDA approved earlier this month.

Thank you for the opportunity! Excited for Monday! Paul Nadira Hamid vinayak bapat Marcus R. Burns João Cavalcante Peter Eckman Emmanouil Brilakis Yader Sandoval Mario Goessl Nishtha Sodhi American College of Cardiology TCTMD SCAI Now

Proud to be one of the 1st in the world with a team that is passionate about innovation for patients! Last week we were among the 1st to be part of a new study (LEADR LBBAP sponsored by Medtronic) evaluating safety and efficacy of new technology. Read more buff.ly/44wKy4x

🩺 This morning’s #CV Grand Rounds session featured Drs. Michael Miedema and Felipe Martignoni on 'A 2024 Cardiovascular Prevention Update'. ❤️ As always, recordings are available here: buff.ly/43oOCTD | #CV Twitter

Very honored to be invited as speaker for the Fellows Bootcamp on July 17th at #cvi2024 It will be a very interesting session with KOL, providing fellows to develop skills, tools and techniques to succeed. #CVI2024 Mehdi Shishehbor, DO Emmanouil Brilakis Paul Subhash Banerjee CV Innovations

The Fellows Bootcamp: Success with Interventional Fellowship and Beyond is back again for CVI 2024 on 7/17 prior to CVI. Complimentary for #fellows and early-career physicians. Space limited register now:
cvinnovations.org/2024/04/07/fel…

Congratulations to Yader Sandoval , Emmanouil (Manos) Brilakis, João Cavalcante, John Lesser, Victor Cheng, Carlos Collet Bortone, MD, PhD, Jonathon Leipsic, Omar Khalique, MD, FACC, FSCCT, FSCMR, FASE, FSCAI, and all involved for launching this program.

Our team is honored to celebrate the culmination of years of research that has resulted in new technologies for patients 💓 FDA approval of the TriClip system for patients with tricuspid regurgitation has been featured on KSTP. Read more: buff.ly/3TOpLnK #cardiotwitter

MHIF is proud to announce 1st enrollment in the VISTA U.S. early feasibility study—evaluating new transcatheter tricuspid valve technology for severe, debilitating tricuspid valve regurgitation where there are not a lot of options for patients. Read more: buff.ly/3vFbnXd

We’re proud to celebrate Drs. Robert J. Steffen, Robert Fraser, Matthew D. Olson, Yader Sandoval, J. Adam Davis and Mohammad Khasawneh as Mpls.St.Paul Magazine's Top Doctors: 2024 Rising Stars. We're grateful for our physicians who lead research with global impact on #cardiovascular care!

UH UH Harrington Heart & Vascular Institute is proud to announce that Mehdi Shishehbor, DO has been named and awarded as an innovator by Modern Healthcare's 2024 Innovators Awards, with over 200 peer reviewed publications of clinical and academic achievements.

news.uhhospitals.org/News-Releases/…

#SMARTTrial shows superiority of SEV over BEV for performance at 12mo. Landmark trial enrolls “astounding” # of women, panelists noting that these findings not only remarkable on their own but speak to the need to study disease states which disproportionately impact women. #ACC24

🌟Breaking news🌟from #ACC2024 #TAVR SMART trial findings with 87% female enrollment, Evolut meets non-inferiority for clinical outcomes & demonstrating superior valve function at 1 yr. #SMART -trial

nejm.org/doi/full/10.10…

Celebrating the final milestone of research – FDA approved #TriClip #TEER system, an important first-of-its-kind option for patients living with #tricuspid regurgitation. Proud to have been a leading clinical site led by Paul #cardiotwitter Read: buff.ly/3TGH1LF

MHIF research will be well-represented at #ACC24 . MHIF researchers and AHMHI physicians will take part in more than 20 sessions, including 21 posters, 10 moderated posters, 7 podium presentations, and chair or co-chair roles for 5 sessions. Read more: buff.ly/3VOuNn8